Comparison of American Urological Association and Endocrine Society guidelines on testosterone replacement
- 18 October 2021
- journal article
- review article
- Published by Springer Science and Business Media LLC in International Journal of Impotence Research
- Vol. 34 (7), 626-629
- https://doi.org/10.1038/s41443-021-00477-w
Abstract
Low testosterone affects an increasing number of patients each year resulting in a steady increase in prescriptions for testosterone replacement therapy (TRT). In 2018, the American Urological Association (AUA) and the Endocrine Society (ES) published their guidelines for treating patients with low testosterone. While the two guidelines are similar, significant differences exist. In this review, we compare and analyze the AUA and ES guidelines in terms of diagnosis and definition, workup, monitoring of side effects, treatment outcomes for TRT, and how these guidelines are applied in our practice.Keywords
This publication has 13 references indexed in Scilit:
- Testosterone Therapy in Men With Hypogonadism: An Endocrine Society* Clinical Practice GuidelineJournal of Clinical Endocrinology & Metabolism, 2018
- Erythrocytosis Following Testosterone TherapySexual Medicine Reviews, 2017
- Association Between Direct-to-Consumer Advertising and Testosterone Testing and Initiation in the United States, 2009-2013JAMA, 2017
- Total testosterone quantitative measurement in serum by LC-MS/MSClinica Chimica Acta; International Journal of Clinical Chemistry, 2014
- Early Detection of Prostate Cancer: AUA GuidelineJournal of Urology, 2013
- HyperprolactinemiaJournal of Human Reproductive Sciences, 2013
- Prevalence of hypogonadism in males aged at least 45 years: the HIM studyInternational Journal of Clinical Practice, 2008
- Male hypogonadism. Part I: Epidemiology of hypogonadismInternational Journal of Impotence Research, 2005
- Hyperprolactinemia and sexual function in men: a short reviewInternational Journal of Impotence Research, 2003
- Hematocrit and the risk of cardiovascular disease—The Framingham Study: A 34-year follow-upAmerican Heart Journal, 1994